(XYL) Xylem - Ratings and Ratios
Pumps, Valves, Heat Exchangers, Controls, Filtration Equipment, Water Treatment
XYL EPS (Earnings per Share)
XYL Revenue
Description: XYL Xylem
Xylem Inc. is a global leader in the design, manufacture, and servicing of engineered products and solutions for various markets, including utility, industrial, and residential and commercial building services. The companys diverse portfolio includes products and services for water infrastructure, applied water, measurement and control solutions, and water solutions and services.
Xylems product offerings cater to a wide range of applications, including water and wastewater treatment, pumps, valves, and controls. The company operates through four business segments, providing a comprehensive suite of solutions for the water industry. Its brands, such as Flygt, Sensus, and Goulds Water Technology, are recognized for their quality and innovation.
To evaluate Xylems performance, we can examine key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (ROE). With a ROE of 8.55%, Xylem demonstrates a reasonable return on shareholder equity. Additionally, the companys dividend yield and payout ratio can be analyzed to assess its ability to generate consistent returns for investors.
From a valuation perspective, Xylems price-to-earnings (P/E) ratio of 35.30 suggests that the stock may be trading at a premium to its earnings. However, the forward P/E ratio of 28.49 indicates potential for earnings growth. To further assess the companys valuation, we can examine metrics such as enterprise value-to-EBITDA (EV/EBITDA) and price-to-book (P/B) ratio.
Xylems commitment to innovation and sustainability is reflected in its investment in digital solutions, such as cloud-based analytics and remote monitoring, under brands like Xylem Vue. The companys focus on addressing global water challenges positions it for long-term growth and success.
XYL Stock Overview
| Market Cap in USD | 34,214m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2011-10-13 |
XYL Stock Ratings
| Growth Rating | 52.6% |
| Fundamental | 68.9% |
| Dividend Rating | 59.2% |
| Return 12m vs S&P 500 | -9.68% |
| Analyst Rating | 4.05 of 5 |
XYL Dividends
| Dividend Yield 12m | 1.16% |
| Yield on Cost 5y | 1.93% |
| Annual Growth 5y | 6.72% |
| Payout Consistency | 100.0% |
| Payout Ratio | 34.1% |
XYL Growth Ratios
| Growth Correlation 3m | 75.2% |
| Growth Correlation 12m | 28.5% |
| Growth Correlation 5y | 60.2% |
| CAGR 5y | 15.57% |
| CAGR/Max DD 3y | 0.54 |
| CAGR/Mean DD 3y | 1.83 |
| Sharpe Ratio 12m | 0.12 |
| Alpha | 0.01 |
| Beta | 0.860 |
| Volatility | 22.17% |
| Current Volume | 1094k |
| Average Volume 20d | 1170.9k |
| Stop Loss | 136.4 (-3.1%) |
| Signal | -0.93 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (938.0m TTM) > 0 and > 6% of Revenue (6% = 523.7m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.69% (prev 20.71%; Δ 2.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 1.22b > Net Income 938.0m (YES >=105%, WARN >=100%) |
| Net Debt (954.0m) to EBITDA (1.77b) ratio: 0.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (243.9m) change vs 12m ago 0.13% (target <= -2.0% for YES) |
| Gross Margin 37.82% (prev 36.85%; Δ 0.97pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.97% (prev 53.26%; Δ -0.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 33.22 (EBITDA TTM 1.77b / Interest Expense TTM 36.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.47
| (A) 0.12 = (Total Current Assets 4.37b - Total Current Liabilities 2.30b) / Total Assets 17.19b |
| (B) 0.19 = Retained Earnings (Balance) 3.34b / Total Assets 17.19b |
| (C) 0.07 = EBIT TTM 1.20b / Avg Total Assets 16.48b |
| (D) 0.53 = Book Value of Equity 3.12b / Total Liabilities 5.88b |
| Total Rating: 2.47 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.89
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 2.51% = 1.25 |
| 3. FCF Margin 10.09% = 2.52 |
| 4. Debt/Equity 0.19 = 2.48 |
| 5. Debt/Ebitda 1.20 = 1.47 |
| 6. ROIC - WACC (= -1.01)% = -1.26 |
| 7. RoE 8.70% = 0.73 |
| 8. Rev. Trend 87.69% = 6.58 |
| 9. EPS Trend 82.45% = 4.12 |
What is the price of XYL shares?
Over the past week, the price has changed by +2.30%, over one month by +0.18%, over three months by +10.60% and over the past year by +7.24%.
Is Xylem a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XYL is around 137.61 USD . This means that XYL is currently overvalued and has a potential downside of -2.21%.
Is XYL a buy, sell or hold?
- Strong Buy: 9
- Buy: 5
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the XYL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 156.2 | 11% |
| Analysts Target Price | 156.2 | 11% |
| ValueRay Target Price | 154.3 | 9.6% |
Last update: 2025-09-09 04:51
XYL Fundamental Data Overview
CCE Cash And Equivalents = 1.17b USD (last quarter)
P/E Trailing = 36.6042
P/E Forward = 26.2467
P/S = 3.9191
P/B = 3.0895
P/EG = 2.3207
Beta = 1.089
Revenue TTM = 8.73b USD
EBIT TTM = 1.20b USD
EBITDA TTM = 1.77b USD
Long Term Debt = 1.93b USD (from longTermDebt, last quarter)
Short Term Debt = 196.0m USD (from shortTermDebt, last quarter)
Debt = 2.12b USD (Calculated: Short Term 196.0m + Long Term 1.93b)
Net Debt = 954.0m USD (from netDebt column, last quarter)
Enterprise Value = 35.17b USD (34.21b + Debt 2.12b - CCE 1.17b)
Interest Coverage Ratio = 33.22 (Ebit TTM 1.20b / Interest Expense TTM 36.0m)
FCF Yield = 2.51% (FCF TTM 881.0m / Enterprise Value 35.17b)
FCF Margin = 10.09% (FCF TTM 881.0m / Revenue TTM 8.73b)
Net Margin = 10.75% (Net Income TTM 938.0m / Revenue TTM 8.73b)
Gross Margin = 37.82% ((Revenue TTM 8.73b - Cost of Revenue TTM 5.43b) / Revenue TTM)
Tobins Q-Ratio = 11.27 (Enterprise Value 35.17b / Book Value Of Equity 3.12b)
Interest Expense / Debt = 0.42% (Interest Expense 9.00m / Debt 2.12b)
Taxrate = 18.12% (197.0m / 1.09b)
NOPAT = 979.2m (EBIT 1.20b * (1 - 18.12%))
Current Ratio = 1.90 (Total Current Assets 4.37b / Total Current Liabilities 2.30b)
Debt / Equity = 0.19 (Debt 2.12b / last Quarter total Stockholder Equity 11.07b)
Debt / EBITDA = 1.20 (Net Debt 954.0m / EBITDA 1.77b)
Debt / FCF = 2.41 (Debt 2.12b / FCF TTM 881.0m)
Total Stockholder Equity = 10.78b (last 4 quarters mean)
RoA = 5.46% (Net Income 938.0m, Total Assets 17.19b )
RoE = 8.70% (Net Income TTM 938.0m / Total Stockholder Equity 10.78b)
RoCE = 9.41% (Ebit 1.20b / (Equity 10.78b + L.T.Debt 1.93b))
RoIC = 7.66% (NOPAT 979.2m / Invested Capital 12.79b)
WACC = 8.66% (E(34.21b)/V(36.34b) * Re(9.18%)) + (D(2.12b)/V(36.34b) * Rd(0.42%) * (1-Tc(0.18)))
Shares Correlation 3-Years: 96.19 | Cagr: 2.75%
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.84% ; FCFE base≈884.6m ; Y1≈1.09b ; Y5≈1.86b
Fair Price DCF = 105.6 (DCF Value 25.70b / Shares Outstanding 243.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 82.45 | EPS CAGR: 18.50% | SUE: 2.01 | # QB: 3
Revenue Correlation: 87.69 | Revenue CAGR: 20.43% | SUE: N/A | # QB: None
Additional Sources for XYL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle